Bite (noun): more meaty news to sink your teeth into.
Bark (noun): peripheral noise worth your attention.
This week in Other Barks & Bites: USPTO Director Vidal announces Federal Register notice on duty of disclosure requirements as Senate Judiciary advances a bill to create a USPTO-FDA interagency task force on drug patents; Senator Thom Tillis tells IAM that he will introduce patent eligibility legislation soon; the Federal Circuit affirms an attorneys’ fees award for forum shopping of patent infringement claims to avoid an adverse Section 101 ruling; both houses of Congress pass major semiconductor production legislation in the CHIPS and Science Act; the Sixth Circuit affirms the dismissal of trade secret claims related to a patent application filed covering a hydraulic actuator invention; Big Tech giants Apple and Amazon.com both post beats on quarterly earnings reports; the Federal Trade Commission files a lawsuit against Meta Platforms to prevent that company’s acquisition of VR firm Within Unlimited; the District of Delaware enters a ruling invalidating Xifaxan patent claims, sending Bausch Health stock down by about 50%; and the Senate Commerce Committee votes to advance the nomination of Dr. Arati Prabhakar to serve as the Director of the White House’s Office of Science and Technology Policy.
Senate Judiciary Advances USPTO-FDA Collaboration Bill as Vidal Issues Notice on Disclosure Duties – On Thursday, July 28, the U.S. Senate Committee on the Judiciary advanced by voice vote S. 4430, the Interagency Patent Coordination and Improvement Act, toward a full vote on the Senate floor. The bill would establish an interagency task force and processes for sharing information on application evaluation practices at the U.S. Patent and Trademark Office (USPTO) and the U.S. Food and Drug Administration (FDA). The same day, USPTO Director Kathi Vidal announced that the agency would issue a notice in the Federal Register clarifying the duties of disclosure and reasonable inquiry of pharmaceutical patent applicants proceeding before the USPTO and FDA in response to urging by Senators to establish interagency communications to eliminate drug patent thickets.
Tillis Tells IAM He’ll Try Again on 101 Reform – Senator Thom Tillis (R-NC) said in an interview with IAM published Thursday that he plans to introduce a bill titled the “Patent Eligibility Restoration Act of 2022” that will take another stab at reforming U.S. patent eligibility law. Tillis told IPWatchdog following his last effort at reforming Section 101 that, without compromise and cooperation among stakeholders, there is little more the Senate IP Subcommittee can do to fix the problems. Even now, although he told IAM he has been speaking with a diverse group of stakeholders over the last year and has presumably reached some kind of consensus, he admitted in the interview that it is not likely any bill on eligibility will be passed within the next two years, and that it will likely be more like four to six.
Senator Wicker Urges Commerce Committee to Take Up House Data Privacy Legislation – On Thursday, July 28, Senator Roger Wicker (R-MS), Ranking Member of the U.S. Senate Committee on Commerce, Science, & Transportation, made remarks during an executive session of the Senate Commerce Committee urging committee members to take up a version of the American Data Privacy Protection Act (ADPPA) recently advanced by the U.S. House of Representatives Energy and Commerce Committee. Passage of such legislation would help promote data privacy of Americans while creating a single national framework for governing the design and operation of covered platforms.
Seventh Circuit Affirms SJ Ruling Nixing Trade Secret Claims Over Actuator Patent Application – On Thursday, July 28, the U.S. Court of Appeals for the Seventh Circuit issued a decision in REXA, Inc. v. Chester in which the appellate court affirmed a summary judgment ruling entered in the Northern District of Illinois dismissing trade secret misappropriation claims filed against Chester by REXA, the successor-in-interest to Chester’s former employer Koso. The Seventh Circuit found that Chester did not misappropriate a 2002 actuator design developed for Koso in a 2014 patent application filed by Chester for a new actuator. The Seventh Circuit did, however, vacate the district court’s award of attorneys’ fees to Chester as REXA’s litigation conduct, while “disturb[ing],” was insufficient to support a finding of litigation misconduct.
CHIPS and Science Act Passes Both Senate and House of Representatives – On Thursday, July 28, the U.S. Senate voted 64 to 33 in favor of passing the Creating Helpful Incentives to Produce Semiconductors (CHIPS) and Science Act, which earmarks nearly $250 billion in federal funding for various investments into domestic semiconductor production as well as basic science and technology research in critical areas of emerging technology including artificial intelligence, quantum computing and cybersecurity. On the same day, parallel legislation passed in the U.S. House of Representatives by a 243 to 187 vote, sending the bill to the White House for President Joe Biden to sign into law.
CAFC Affirms Attorneys’ Fees to Netflix for Forum-Shopping of Patent Infringement Claims – On Wednesday, July 27, the U.S. Court of Appeals for the Federal Circuit issued a precedential decision in Realtime Adaptive Streaming LLC v. Netflix, Inc. in which the appellate court affirmed the Central District of California’s entry of an attorneys’ fees award to Netflix after finding that Realtime’s decision to voluntarily dismiss a pair of infringement lawsuits filed in Delaware after a magistrate judge recommended invalidating the asserted patent claims under 35 U.S.C. § 101 constituted sanctionable gamesmanship in forum shopping. Circuit Judge Jimmie Reyna authored a partial dissent concurring in the majority’s decision to affirm the attorneys’ fees award but arguing that the district court was correct to consider Realtime’s voluntary dismissals as conferring prevailing party status upon Netflix for purposes of 35 U.S.C. § 285.
FTC Sues to Block Meta’s Acquisition of Within Unlimited – On Wednesday, July 27, the Federal Trade Commission (FTC) filed a lawsuit in the Northern District of California asserting violations of the FTC Act in an attempt to prevent the acquisition of virtual reality (VR) firm Within Unlimited, including its fitness app Supernatural, by social media and VR giant Meta Platforms, which already markets an Oculus Move VR fitness app and could allegedly create a monopoly within the VR fitness app market through its planned acquisition of Within Unlimited.
Senate Commerce Committee Advances Dr. Prabhakar for OSTP Director – On Wednesday, July 27, the U.S. Senate Committee on Commerce, Science, & Transportation voted to advance the Biden Administration’s nomination of Dr. Arati Prabhakar to serve as Director of the White House Office of Science and Technology Policy (OSTP). The favorable vote for Dr. Prabhakar follows about a week after a previous nomination hearing during which Senator Roger Wicker raised questions about Dr. Prabhakar’s business ties to former Google CEO Eric Schmidt.
Second Circuit Find Clear Legal Error in SDNY’s Injunction in “RISE” Trademark Case – On Friday, July 22, the U.S. Court of Appeals for the Second Circuit issued a decision in RiseandShine Corp. v. PepsiCo., Inc. in which the appellate court reversed a preliminary injunction entered by the Southern District of New York against Pepsi’s Mtn DEW Rise Energy beverage. The Second Circuit found that the district court committed clear legal error by failing to acknowledge the logical association between “RISE,” the mark at issue, and energy and coffee drinks, and that several differences in type font and beverage packaging between Pepsi’s beverage and RiseandShine’s RISE-branded coffee drinks undercut the district court’s finding that the marks were confusingly similar.
Derrick Brent Introduced as USPTO Deputy Director – On Thursday, July 28, the U.S. Patent and Trademark Office announced that Derrick Brent, formerly Chief Counsel for former Senator Barbara Boxer (D-CA) and recognized as “a respected authority on 2011’s America Invents Act,” would serve the agency as Deputy Director effective August 1.
Bausch Stock Dips 50% Following Judge Andrews Partial Invalidation of Xifaxan Patent Claims – On Thursday, July 28, U.S. District Judge Richard G. Andrews of the District of Delaware entered an oral order directing both Norwich Pharmaceuticals, a subsidiary of American pharmaceutical firm Alvogen, and Salix Pharmaceuticals, a wholly-owned subsidiary of Canadian pharmaceutical firm Bausch Health, to file a joint proposed final judgment proceeding on the assumption that certain Salix patent claims covering the use of the brand-name drug Xifaxan to treat adults suffering from irritable bowel syndrome with diarrhea. Shares of Bausch Health dropped about 50% in value on the news of Judge Andrews’ order.
Copyright Office Issues New Web Resources for Registering Non-Photographic Databases – On Thursday, July 28, the U.S. Copyright Office announced that the agency had launched a new web page including resources and general guidance for copyright applicants seeking to register automated databases that do not primarily consist of photographs, including registration options for either an individual version of a database or group registrations of up to three months of database updates.
Judge Silva Grants Parler’s Motion to Dismiss Stylized “P” Trademark Claims – On Wednesday, July 27, U.S. District Judge Cristina D. Silva of the District of Nevada issued a ruling granting social media firm Parler’s motion to dismiss trademark infringement claims brought by 46 Labs, which offers a user interface for communication infrastructure branded as Peeredge. Judge Silva found that 46 Labs did not plead facts showing that 46 Labs and Parler compete with similar services.
USPTO Director Vidal Announces Innovation Internship, First-Time Filer Inclusivity Initiatives – On Wednesday, July 27, a blog post published on USPTO’s Director’s Blog and authored by Director Kathi Vidal announced new initiatives developed with input from the USPTO’s Council for Inclusive Innovation (CI2) to increase inclusivity in the U.S. innovation systems. Those initiatives include a new paid internship program for community college and university students as well as a fast-track program providing expedited examination of patent applications from first-time micro entity filers.
USITC Issues General Exclusion Order in Section 337 Investigation on Battery Technology – On Monday, July 25, the U.S. International Trade Commission terminated a Section 337 investigation into certain battery products and components thereof imported into the U.S. for sale by a series of 13 Chinese entities based on a complaint for patent infringement filed by One World Technologies and Techtronic Power Tools Technology. The USITC found Section 337 violations committed by the respondents and entered a general exclusion order prohibiting the importation of patent infringing battery technologies.
CAFC Announces Minor Revision to Internal Operating Procedures – On Friday, July 22, the U.S. Court of Appeals for the Federal Circuit announced that the court had made a minor stylistic alteration to Internal Operating Procedure #14(2)(e), which governs a panel majority’s ability to make substantive changes to an issued decision before a majority of active judges vote to grant a petition for rehearing en banc.
EUIPO to Launch New Electronic Trademark Filing Form in August – On Wednesday, July 20, the European Union Intellectual Property Office (EUIPO) announced that beginning on August 1, the agency would begin accepting trademark registration applications via a new electronic form designed to be more user-friendly including new customization options and contextual guidance for applicants.
This Week on Wall Street
Apple Posts Quarterly Earnings Beat on Revenue and EPS – On Thursday, July 28, consumer device giant Apple reported earnings for the third quarter of the 2022 fiscal year showing that the firm beat analyst expectations both on revenue ($83 billion vs. $82.81 billion expected) and earnings per share ($1.20 per share vs. $1.16 per share expected), helping Apple shares rise by about 3% in extended trading.
Amazon Earnings Beat Estimates Thanks to 33% Increase in Cloud Revenues – On Thursday, July 28, e-commerce giant Amazon.com issued its earnings report for the second quarter of the 2022 fiscal year showing that revenues for the company’s cloud computing sector increased by 33% during the recent quarter to $19.74 billion, beating analyst expectations of $19.56 billion in cloud revenues, although operating income for Amazon Web Services only reached $5.72 billion, below expectations of $6.04 billion in operating income for Amazon’s cloud division.
Quarterly Earnings – The following firms identified among the IPO’s Top 300 Patent Recipients for 2021 are announcing quarterly earnings next week (2020 rank in parentheses:
- Monday: Innolux Corp. (267th); On Semiconductor Corp. (t-170th); Sumitomo Chemical Co. (182nd); TDK Corp. (81st)
- Tuesday: Advanced Micro Devices, Inc. (t-197th); Daikin Industries, Ltd. (t-236th); Eaton Corp. plc (t-141st); Fresenius SE & Co. KGaA (t-239th); Honda Motor Co., Ltd. (30th); Paypal Holdings, Inc. (131st); Zimmer Biomet Holdings. Inc. (283rd)
- Wednesday: Bayerische Motoren Werke AG (t-129th); Borgwarner Inc. (t-281st); Casio Computer Co., Ltd. (t-277th); Infineon Technologies AG (65th); Mitsubishi Chemical Group Corp. (t-205th); Qorvo, Inc. (t-295th); Ricoh Co., Ltd. (56th); Sumitomo Electric Industries Ltd. (62nd); Wistron Corp. (t-272nd); Yamaha Corp. (209th)
- Thursday: Bayer AG (84th); Becton Dickinson and Co. (133rd); Merck KGaA (212th); Nikon Corp. (t-254th); Nippon Steel Corp. (181st); Novo Nordisk A/S (300th); Schaeffler AG (t-186th); Softbank Group Corp. (76th); Toyota Motor Corp. (8th)
- Friday: Berkshire Hathaway Inc. (230th); Carl Zeiss Meditec AG (143rd); Novatek Microelectronics Corp. (t-289th); Sharp Corp. (50th); Shimadzu Corp. (180th); Western Digital Corp. (57th)
Image Source: Deposit Photos
Warning & Disclaimer: The pages, articles and comments on IPWatchdog.com do not constitute legal advice, nor do they create any attorney-client relationship. The articles published express the personal opinion and views of the author as of the time of publication and should not be attributed to the author’s employer, clients or the sponsors of IPWatchdog.com. Read more.
What is the CHIPS and Science Act of 2022? ›
The CHIPS and Science Act of 2022 invests billions over the next five years to help the U.S. regain a leading position in semiconductor chip manufacturing. H.R. 4346, which houses the act, includes an additional $20 million to protect members of the U.S. Supreme Court and their families.What is the CHIP bill that just passed? ›
The CHIPS and Science Act will unlock hundreds of billions more in private sector semiconductor investment across the country, including production essential to national defense and critical sectors. The law will also ensure the United States maintains and advances its scientific and technological edge.Did the Senate pass the CHIPS Act? ›
WASHINGTON, D.C. – Today, the U.S. Senate passed a legislative package that includes the CHIPS Act of 2022, which includes historic funding for domestic semiconductor manufacturing as well as a Science Title with funding for essential priorities for Ohio's economy.What does the chip Act do? ›
In July 2022, Congress passed the CHIPS Act of 2022 to strengthen domestic semiconductor manufacturing, design and research, fortify the economy and national security, and reinforce America's chip supply chains.Who will benefit from the chips act? ›
Intel Seen As Top CHIPS Act Winner
Intel (INTC) likely will be the biggest beneficiary of the CHIPS Act, BofA Securities analyst Vivek Arya said in a recent note to clients. He estimated Intel could see $10 billion to $15 billion worth of U.S. government subsidies over the next five years.
To receive funding, a recipient must enter into an agreement with the Department of Commerce to operationalize the expansion clawback restrictions. Key Terminology Undefined. “Semiconductor manufacturing” will be defined by the Department of Commerce and includes front-end semiconductor fabrication.Who manufactures microchips in the United States? ›
1. Intel Corporation (Leading Semiconductor Company in USA) Intel is world leader in silicon innovation develops processor technologies and supports global initiatives.Are any microchips made in USA? ›
In 1990, the U.S. produced 37 percent of the world's semiconductors. But in part due to subsidies to semiconductor manufacturers by China, the European Union, Taiwan, South Korea, and others, today, just 12 percent of semiconductors are manufactured in the United States.What US company makes semiconductor chips? ›
Intel Corporation is the world's largest semiconductor chip maker based on its 2020 sales. It is the inventor of the x86 series of microprocessors found in most personal computers today.What percentage of semiconductors are made in USA? ›
America let itself fall behind on semiconductors
In the late 1940s and 1950s, America led the world in semiconductor manufacturing. Today only 12% of semiconductors are made in America; 80% are made in Asia. And none of the most advanced semiconductors are manufactured on U.S. soil.
Has the CHIPS Act been approved? ›
On August 9, 2022, President Biden signed the CHIPS and Science Act (H.R. 4346), which seeks to bolster the US semiconductor supply chain and promote research and development of advanced technologies in the United States.Will AMD benefit from CHIPS Act? ›
Fabless chip companies like AMD, Nvidia and Qualcomm that design chips but do not manufacture them would see no direct benefit from subsidies to build plants or tax benefits for production tools.How will CHIPS Act funds be distributed? ›
Specifically, the funds will be made available as loan guarantees and subsidies or grants and cooperative agreements, and the department has said that it hopes to focus more on loan underwriting in order to maximize how far the CHIPS Act dollars will go.What is Biden's CHIPS Act? ›
Signed into law this August, the CHIPS and Science Act provides $52 billion in semiconductor manufacturing subsidies to incentivize companies to build, expand, or modernize domestic semiconductor facilities. It also includes a 25 percent tax credit to encourage investments in semiconductor manufacturing.What is the chip 4 Alliance? ›
A little over a year ago, the U.S. government proposed forming the so-called Chip 4 alliance comprising the USA, Japan, South Korea, and Taiwan to secure the global semiconductor supply chain, coordinate policies, subsidies, and joint research and development (R&D) projects.What is in inflation Reduction Act of 2022? ›
The Inflation Reduction Act will protect Medicare recipients from catastrophic drug costs by phasing in a cap for out-of-pocket costs and establishing a$35 cap for a month's supply of insulin. And, as an historic win, Medicare will be able to negotiate prices for high-cost drugs for the first time ever.What is in the 280 billion CHIPS Act? ›
By the numbers: The CHIPS Act directs $280 billion in spending over the next ten years. The majority—$200 billion—is for scientific R&D and commercialization. Some $52.7 billion is for semiconductor manufacturing, R&D, and workforce development, with another $24 billion worth of tax credits for chip production.What does chips stand for in the CHIPS and Science Act? ›
The law does not have an official short title as a whole but is divided into three divisions with their own short titles: Division A is the CHIPS Act of 2022 (where CHIPS stands for "Creating Helpful Incentives to Produce Semiconductors"); Division B is the Research and Development, Competition, and Innovation Act; and ...Who voted against the CHIPS Act? ›
Hyde-Smith voted against the CHIPS Act (HR. 4346), which was approved on a 64-33 vote. The bill now goes to the House of Representatives, where it is expected to be approved and cleared for consideration by the President.